Table 1.
Tool | Description | Study | Database | Relevant Result | Validated Method for Identifying HE or Cirrhosis | Limitations | Benefits |
---|---|---|---|---|---|---|---|
International Classification of Diseases, 9th Revision (ICD-9) |
|
V. Lo Re et al. (2011) |
|
Nine of 295 patients with an ICD-9 code or laboratory value indicating liver dysfunction had an ICD-9 code for HE; the PPV of this code was 0.11 and estimated NPV of 0.99 | HE | ICD-9 is not being coded in the United States after 2015, so available data ranges are limited; Variable accuracy in coding | International; Currently best validated; Specific code for HE |
Goldberg et al. (2012) |
|
Presence of one inpatient or outpatient ICD-9 code for cirrhosis, chronic liver disease, and a hepatic decompensation (of which HE was one), the PPV of 0.85 for confirmed cirrhosis | Cirrhosis | ||||
Kanwal et al. (2012) |
|
After identifying cirrhosis patients with ICD-9 codes and laboratory data, at least one ICD-9 code for HE had PPV of 0.86 and NPV of 0.87 for confirmed HE | HE | ||||
Nehra et al. (2013) |
|
ICD-9 code for HE had PPV 0.92 and NPV 0.36 for identifying confirmed cirrhosis; did not report if it identified HE | Cirrhosis | ||||
Lapointe-Shaw et al. (2018) |
|
Having a single hospital diagnostic code for cirrhosis, including 572.2, was specific for cirrhosis (0.91–0.96 depending on subcohort), but not as sensitive (0.57–0.77); however, the authors did not specify in how many cases 572.2 was used vs. other codes | Cirrhosis | ||||
International Classification of Diseases, 10th Revision (ICD-10) |
|
Thygesen et al. (2011) |
|
The PPV of one inpatient or outpatient ICD-10 code for moderate/severe liver disease, which included K72.90, correctly identifying cirrhosis was 1.00; however, the authors did not specify in how many cases K72.90 was used vs. other codes | Cirrhosis | Only available in the United States 2015 and thereafter | International; Required to use data after 2015 in the United States; Readily available in most databases |
Mapakshi et al. (2018) |
|
Unable to validate the use of ICD-10 codes for HE because there were no HE events during the study period | Neither | ||||
Tapper et al. (2020) |
|
In a validation cohort of veterans with HCV, ICD-10 code K72.90 identified development of HE with PPV 0.90 and NPV 0.93 | HE | ||||
Lapointe-Shaw et al. (2018) |
|
Having a single hospital diagnostic code for cirrhosis, including K72.90, was specific for cirrhosis (0.91–0.96 depending on subcohort), but not as sensitive (0.57–0.77); however, the authors did not specify in how many cases K72.90 was used vs. other codes | Cirrhosis | ||||
Prescription Data |
|
Tapper et al. (2020) |
|
In a validation cohort of veterans with HCV, lactulose prescription had PPV of 0.73 and NPV of 0.99 for HE diagnosis, while lactulose or rifaximin prescription had a PPV of 0.71 and NPV of 0.99 | HE | Not available in every database | Lactulose therapy for overt HE is nearly uniform |
Combination |
|
Kaplan et al. (2015) |
|
An algorithm based on the ICD-9 code for HE and prescription fills for lactulose or rifaximin had weighted kappa agreement of 0.51 with the CTP-subscore for HE | HE | Not available in every database | Using multiple modalities in one algorithm can enhance predictive value |
ICD, International Classification of Diseases; PPV, positive predictive value; NPV, negative predictive value; CTP, Child-Turcotte-Pugh.